Skip to main content
Premium Trial:

Request an Annual Quote

PhenoBiome Inks US Distribution Deal With Genetic Direction for Gut Microbiome Assay Service

NEW YORK — PhenoBiome said on Thursday that it has signed a nonexclusive US distribution deal for its direct-to-consumer GxGutHealth gut microbiome assay service with Genetic Direction.

According to PhenoBiome, GxGutHealth assesses an individual's gut microbiome and provides a report that can guide behavioral and other health interventions to improve gut health. The assays are processed by Eurofins subsidiary Clinical Enterprise.

On its website, PhenoBiome says its platform converts taxonomic signatures from 16S sequence data and gene lists into microbiome-wide quantitative functional capabilities. It deduces metabolic phenotypes reflecting the presence or absence of a pathway in all microbes from parts lists using a genome-based in silico reconstruction method.

Under the terms of the deal, Genetic Direction, a Dallas-based distributor of consumer genetic testing products, will offer GxGutHealth through its 900 affiliates throughout the US. Additional terms were not disclosed.

"Through more than a decade of research, our science team has identified the specific bacteria that contribute to more than 100 physiological functions in the human body and built a test that provides a complete and accurate picture of an individual patient's gut microbiome," Pavel Novichkov, PhenoBiome's cofounder and chief technology officer, said in a statement.

Palm Springs, California-based PhenoBiome also said that it has begun collaborating with an undisclosed animal health company to apply its gut microbiome technology to animal health and that it is planning to expand into additional markets including personalized prebiotics, probiotics, and food supplements.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.